Intravenous administration of BCG in mice promotes natural killer and T cell-mediated antitumor immunity in the lung

Intravesical administration of Bacillus Calmette-Guérin (BCG) was one of the first FDA-approved immunotherapies and remains a standard treatment for bladder cancer. Previous studies have demonstrated that intravenous (IV) administration of BCG is well-tolerated and effective in preventing tuberculos...

Descripción completa

Detalles Bibliográficos
Autores principales: Moreo, Eduardo, Jarit-Cabanillas, Aitor, Robles-Vera, Iñaki, Uranga, Santiago, Guerrero, Claudia, Gómez, Ana Belén, Mata-Martínez, Pablo, Minute, Luna, Araujo-Voces, Miguel, Felgueres, María José, Esteso, Gloria, Uranga-Murillo, Iratxe, Arias, Maykel, Pardo, Julián, Martín, Carlos, Valés-Gómez, Mar, del Fresno, Carlos, Sancho, David, Aguiló, Nacho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10551006/
https://www.ncbi.nlm.nih.gov/pubmed/37794033
http://dx.doi.org/10.1038/s41467-023-41768-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10551006/
https://www.ncbi.nlm.nih.gov/pubmed/37794033
http://dx.doi.org/10.1038/s41467-023-41768-8

Ejemplares similares